Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

E Pérez-Herrero, A Fernández-Medarde - European journal of …, 2015 - Elsevier
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …

Recent developments in natural biopolymer based drug delivery systems

T Fazal, BN Murtaza, M Shah, S Iqbal, M Rehman… - RSC …, 2023 - pubs.rsc.org
Targeted delivery of drug molecules to diseased sites is a great challenge in pharmaceutical
and biomedical sciences. Fabrication of drug delivery systems (DDS) to target and/or …

IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy

C Yue, P Liu, M Zheng, P Zhao, Y Wang, Y Ma, L Cai - Biomaterials, 2013 - Elsevier
IR-780 iodide is a near-infrared (NIR) fluorescence dye with higher and more stable
fluorescence intensity than clinically applied dye indocyanine green (ICG). Meanwhile, IR …

Polymeric nanomedicine for cancer therapy

JH Park, S Lee, JH Kim, K Park, K Kim… - Progress in polymer …, 2008 - Elsevier
Nanomedicine, an offshoot of nanotechnology, refers to highly specific, molecular-scale
medical intervention for treating disease or repairing damaged tissues. In recent years …

Dendronized heparin− doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy

W She, N Li, K Luo, C Guo, G Wang, Y Geng, Z Gu - Biomaterials, 2013 - Elsevier
Heparin drug conjugates are currently investigated as excellent candidates for drug delivery
vehicles. In this study, we report the preparation and characterization of dendronized …

PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo

KY Choi, KH Min, HY Yoon, K Kim, JH Park, IC Kwon… - Biomaterials, 2011 - Elsevier
A major drawback of hyaluronic acid (HA)-based drug conjugates or nanoparticles for
cancer therapy is their preferential accumulation in the liver after systemic administration. In …

Kinetic analysis of drug release from nanoparticles

M Barzegar-Jalali - Journal of Pharmacy & …, 2008 - journals.library.ualberta.ca
PURPOSE. Comparative drug release kinetics from nanoparticles was carried out using
conventional and our novel models with the aim of finding a general model applicable to …

Recent progress of nanocarrier-based therapy for solid malignancies

QY Wei, YM Xu, ATY Lau - Cancers, 2020 - mdpi.com
Simple Summary Although conventional anti-cancer drugs have been the footstone in the
fight against cancer, yet they are far from optimal due to issues related with indiscriminate …

Carbohydrate-based amphiphilic nano delivery systems for cancer therapy

K Liu, X Jiang, P Hunziker - Nanoscale, 2016 - pubs.rsc.org
Nanoparticles (NPs) are novel drug delivery systems that have been attracting more and
more attention in recent years, and have been used for the treatment of cancer, infection …

[HTML][HTML] Advances of cancer therapy by nanotechnology

X Wang, Y Wang, ZG Chen… - Cancer research and …, 2009 - synapse.koreamed.org
Recent developments in nanotechnology offer researchers opportunities to significantly
transform cancer therapeutics. This technology has enabled the manipulation of the …